June 3, 2009 - The Chalk River Laboratories (CRL) nuclear reactor, which supplies about a third of the world’s medical isotopes, has been shut down since May 14 and is not expected to be back for at least three months, according to Atomic Energy of Canada Ltd. (AECL). The reactor produces medical isotopes such as molybdenum-99 (Mo-99), which are used in diagnostic nuclear imaging scans.

June 2, 2009 – During their report Friday at the 63rd Annual Meeting of the Society for Vascular Surgery, Seshadri Raju, M.D., FACS, and other researchers from the University of Mississippi in Jackson offered details about how many patients with severe symptoms of chronic venous insufficiency (CVI) often can be treated with newer, minimally invasive stent treatment without surgery.

June 2, 2009 - IDEAL LIFE Inc. and home care agency Bayada Nurses Inc. said today hospitalizations for patients using IDEAL LIFE’s remote health management products for congestive heart failure (CHF) and hypertension decreased 40 to 60 percent since the program began in September 2007.

June 1, 2009 - Devax Inc. today said FDA has conditionally approved an investigational device exemption (IDE) for its AXXESS Biolimus A9-Eluting Bifurcation Stent System, allowing the company to initiate a pivotal clinical trial (DIVERGE II) of the device in the U.S.

June 1, 2009 - A new study shows about 2 percent of 18,165 patients undergoing cardiac catheterization had femoral vascular complications. The study conducted by the Bad Berka Central Clinic, Department of Cardiology in Germany, appears in the June 12 issue of the International Journal of Cardiology (Volume 135, June 12, 2009, Issue 1, Pages 66-71).

May 28, 2009 - Lantheus Medical Imaging Inc. has completed patient enrollment of CaRES (Contrast Echocardiography REgistry for Safety Surveillance), the first, multicenter Phase IV observational registry that evaluates the use of ultrasound imaging agents in routine clinical practice. The 1,060 patients who were enrolled at 15 sites in the U.S.